The results from a randomized, placebo-controlled trial showed that oral probiotic supplementation did not reduce the recurrence of vulvovaginal infections in pregnant women following successful treatment....
In an FDA panel held on July 21, 2025, experts discussed the nuances of risk-benefit counseling and stronger warnings for selective serotonin reuptake inhibitors (SSRIs) to ensure informed consent among...
In women aged 65 years or older post–hip fracture, testosterone plus exercise did not improve long-distance walking more than exercise alone, though researchers observed some gains.
Obstructive sleep apnea (OSA) is more prevalent and complex than often recognized—especially in women, older adults, and patients with comorbid conditions, according to Julianne Blythe, MPA, PA-C, RPSGT, a...
In a recent study, most patients who initiated urate-lowering therapy could achieve a patient-acceptable symptom state or low disease activity within 6 to12 months, with lower flare burden associated with...
A new analysis of national inpatient data reveals that women with both diabetes and polycystic ovary syndrome (PCOS) experience similar hospital outcomes to those without PCOS but face a significantly lower...
A nationwide analysis of over 1.4 million hospitalizations of patients with diabetic ketoacidosis revealed gender-based differences in cardiovascular outcomes. Men had higher rates of mortality and...
A randomized, double-blind, placebo-controlled crossover study found that a single 300 mg dose of palmitoylethanolamide significantly reduced acute menstrual pain compared with placebo at multiple early...
In a large multicenter randomized trial, intrapartum oral sildenafil citrate did not reduce adverse perinatal outcomes related to fetal hypoxia compared with placebo.
A retrospective study presented at the American Society of Clinical Oncology 2025 annual meeting evaluated women with endometrial neuroendocrine tumors and found that adjuvant treatment with...
